QT Vascular launches IPO at 28 cents each for Catalist listing
QT Vascular has launched its initial public offering (IPO) for a Catalist listing with an offer of 196.4 million shares
Pioneering Medical Innovations
QT Vascular has launched its initial public offering (IPO) for a Catalist listing with an offer of 196.4 million shares
PLEASANTON, Calif., May 23, 2012 /PRNewswire/ — TriReme Medical, Inc. (TMI) today announced approval by the U.S. Food and Drug
Novel Design of Chocolate is Aimed at Improving Patient Outcomes PLEASANTON, Calif., Dec. 21, 2011 /PRNewswire/ — TriReme Medical, Inc.
PLEASANTON, Calif., May 9, 2011 /PRNewswire/ — TriReme Medical, Inc. (TriReme), a leading developer of innovative catheters and stents for
PLEASANTON Calif., SINGAPORE and TOKYO, Jan. 10, 2011 /PRNewswire/ — TriReme Medical, Inc. (TriReme) today announced that it has signed